CLIC4
gene geneOn this page
Also known as DKFZP566G223CLIC4LP64H1H1huH1
Summary
CLIC4 (CLIC family member 4, HGNC:13518) is a protein-coding gene on chromosome 1p36.11, encoding Chloride intracellular channel protein 4 (Q9Y696). In the soluble state, catalyzes glutaredoxin-like thiol disulfide exchange reactions with reduced glutathione as electron donor.
Chloride channels are a diverse group of proteins that regulate fundamental cellular processes including stabilization of cell membrane potential, transepithelial transport, maintenance of intracellular pH, and regulation of cell volume. Chloride intracellular channel 4 (CLIC4) protein, encoded by the CLIC4 gene, is a member of the p64 family; the gene is expressed in many tissues and exhibits a intracellular vesicular pattern in Panc-1 cells (pancreatic cancer cells).
Source: NCBI Gene 25932 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 28 total — 1 likely-pathogenic
- Druggable target: yes
- MANE Select transcript:
NM_013943
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13518 |
| Approved symbol | CLIC4 |
| Name | CLIC family member 4 |
| Location | 1p36.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP566G223, CLIC4L, P64H1, H1, huH1, p64H1 |
| Ensembl gene | ENSG00000169504 |
| Ensembl biotype | protein_coding |
| OMIM | 606536 |
| Entrez | 25932 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000374379, ENST00000488683, ENST00000489758, ENST00000497755, ENST00000889870, ENST00000951855
RefSeq mRNA: 1 — MANE Select: NM_013943
NM_013943
CCDS: CCDS256
Canonical transcript exons
ENST00000374379 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001129581 | 24839860 | 24840041 |
| ENSE00001324395 | 24840773 | 24844321 |
| ENSE00001463371 | 24745447 | 24745625 |
| ENSE00003510823 | 24797742 | 24797851 |
| ENSE00003512137 | 24814094 | 24814219 |
| ENSE00003588080 | 24827010 | 24827116 |
Expression profiles
Bgee: expression breadth ubiquitous, 291 present calls, max score 99.67.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 218.5852 / max 2346.3974, expressed in 1806 samples.
FANTOM5 promoters (18 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 1435 | 179.8019 | 1787 |
| 1434 | 20.8621 | 1772 |
| 1436 | 5.9633 | 1487 |
| 1433 | 2.3128 | 1053 |
| 1450 | 1.7295 | 824 |
| 1446 | 1.3986 | 670 |
| 1454 | 1.3041 | 616 |
| 1447 | 0.9488 | 472 |
| 1453 | 0.8289 | 355 |
| 1452 | 0.8284 | 360 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| blood vessel layer | UBERON:0004797 | 99.67 | gold quality |
| saphenous vein | UBERON:0007318 | 99.59 | gold quality |
| cauda epididymis | UBERON:0004360 | 99.46 | gold quality |
| popliteal artery | UBERON:0002250 | 99.39 | gold quality |
| tibial artery | UBERON:0007610 | 99.39 | gold quality |
| vena cava | UBERON:0004087 | 99.38 | gold quality |
| aorta | UBERON:0000947 | 99.35 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 99.35 | gold quality |
| thoracic aorta | UBERON:0001515 | 99.30 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 99.29 | gold quality |
| ascending aorta | UBERON:0001496 | 99.28 | gold quality |
| urethra | UBERON:0000057 | 99.26 | gold quality |
| right coronary artery | UBERON:0001625 | 99.26 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 99.25 | gold quality |
| cartilage tissue | UBERON:0002418 | 99.25 | gold quality |
| calcaneal tendon | UBERON:0003701 | 99.23 | gold quality |
| lower lobe of lung | UBERON:0008949 | 99.22 | gold quality |
| pericardium | UBERON:0002407 | 99.18 | gold quality |
| seminal vesicle | UBERON:0000998 | 99.15 | gold quality |
| superficial temporal artery | UBERON:0001614 | 99.13 | gold quality |
| left coronary artery | UBERON:0001626 | 99.10 | gold quality |
| heart right ventricle | UBERON:0002080 | 99.09 | gold quality |
| coronary artery | UBERON:0001621 | 99.08 | gold quality |
| adult organism | UBERON:0007023 | 99.04 | gold quality |
| mucosa of stomach | UBERON:0001199 | 98.98 | gold quality |
| decidua | UBERON:0002450 | 98.96 | gold quality |
| stromal cell of endometrium | CL:0002255 | 98.94 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 98.92 | gold quality |
| parietal pleura | UBERON:0002400 | 98.88 | gold quality |
| myometrium | UBERON:0001296 | 98.87 | gold quality |
Single-cell (SCXA)
Detected in 16 experiment(s), a significant marker in 15.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8530 | yes | 500.65 |
| E-MTAB-9388 | yes | 374.70 |
| E-MTAB-8142 | yes | 133.99 |
| E-GEOD-84465 | yes | 27.80 |
| E-MTAB-6678 | yes | 26.54 |
| E-HCAD-11 | yes | 24.13 |
| E-GEOD-135922 | yes | 22.64 |
| E-MTAB-5061 | yes | 11.26 |
| E-CURD-46 | yes | 10.66 |
| E-GEOD-81547 | yes | 8.21 |
| E-GEOD-83139 | yes | 6.97 |
| E-MTAB-9543 | yes | 6.60 |
| E-ENAD-27 | yes | 6.17 |
| E-HCAD-25 | yes | 4.75 |
| E-MTAB-10137 | no | 3.86 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): MYC, NKX3-1
miRNA regulators (miRDB)
155 targeting CLIC4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-22-3P | 99.93 | 68.13 | 917 |
Literature-anchored findings (GeneRIF, showing 40)
- CLIC4 is differentially regulated in fibroblasts and its expression contributes to a myofibroblast phenotype (PMID:12163372)
- CLIC4 has alternate cellular functions that are distinct from their proposed roles as chloride channels (PMID:14569596)
- subcellular localization of CLIC4 in endothelial cells was dependent on whether cells were engaged in proliferation or tube formation (PMID:16239224)
- up-regulation of mitochondrial CLIC4, together with a reduction in Bcl-2 and Bcl-xL, sensitizes Myc-expressing cells to the proapoptotic action of Bax. (PMID:16316993)
- preliminary crystallographic analysis (PMID:16842122)
- CLIC4 in tumor stroma has a role in myofibroblast conversion in human neoplasms (PMID:17200346)
- Nuclear CLIC4, possibly by altering the Cl(-) and pH of the nucleus, contributes to cell cycle arrest and the specific gene expression program associated with keratinocyte terminal differentiation. (PMID:17636002)
- Data showed that CLIC1 and CLIC5, but not CLIC4, were strongly and reversibly inhibited (or inactivated) by F-actin. (PMID:18028448)
- CLIC4 functions to promote endothelial cell proliferation and to regulate endothelial morphogenesis, and is thus involved in multiple steps of in vitro angiogenesis. (PMID:19247789)
- ROS-initiated CLIC4 up-regulation is required for TGF-beta1-induced fibroblast-to-myofibroblast transdifferentiaton in ovarian cancer. (PMID:19639201)
- S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. (PMID:19713532)
- Data suggest that CLIC4 is regulated by RhoA to be targeted to the plasma membrane, where it may function not as an inducible chloride channel but rather by displaying Cys-dependent transferase activity toward a yet unknown substrate. (PMID:19776349)
- CLIC4 may not be responsible for benign familial infantile seizures (BFIS) in a Chinese family affected with BFIS. (PMID:20374090)
- Reduced CLIC4 expression and nuclear residence detected in cancer cells is associated with the altered redox state of tumor cells and the absence of detectable nuclear CLIC4 in cancers contributes to TGF-beta resistance and enhances tumor development. (PMID:22387366)
- These results demonstrate that CLIC4 nuclear translocation is an integral part of the cellular response to starvation. (PMID:22761775)
- Our data indicate that CLIC4 protein may be a key element in the apoptotic response to oxidative stress. (PMID:23380911)
- CLIC4 increases tumor cell migration and invasion in a TGF-beta-dependent manner. (PMID:23416981)
- In addition to CLIC1 and TPM1, which were the proteins initially discovered in a xenograft mouse model, CLIC4, TPM2, TPM3, and TPM4 were present in ovarian cancer patient sera at significantly elevated levels compared with controls. (PMID:23792823)
- This study investigated the proteome modulated by oncogenic KRAS in immortalized airway epithelial cells. (PMID:24503901)
- Increased CLIC4 expression is an early manifestation and mediator of endothelial dysfunction in pulmonary hypertension. (PMID:24503951)
- CLIC4, ERp29, and Smac/DIABLO integrated into a novel panel based on cancer stem-like cells in association with metastasis stratify the prognostic risks of colorectal cancer. (PMID:24916695)
- CLIC4 knockdown decreases cell-matrix adhesion, cell spreading and integrin signaling, whereas it increases cell motility. (PMID:25344254)
- CLIC1 and CLIC4 are overexpressed in specific tumor types or their corresponding stroma and change localization and function from hydrophilic cytosolic to integral transmembrane proteins. (Review) (PMID:25546839)
- in malignant pleural mesothelioma, the gene expressions of CLIC3 and CLIC4 were significantly increased compared to controls (PMID:26445368)
- CLIC4 and Ihh could serve as biological markers for the progression, metastasis and/or invasiveness of pancreatic ductal adenocarcinoma. (PMID:28205343)
- High CLIC4 expression is associated with Merkel cell polyomavirus positive Merkel cell carcinoma. (PMID:29462791)
- Results provide evidence that the G4 structure formed in the CLIC4 promoter region may act as a regulatory element in regulating CLIC4 gene transcription. (PMID:30201851)
- These results suggest CLIC1 and CLIC4 are promising serum and tissue biomarkers as well as potential therapeutic targets for all EOC subtypes. This justifies development of high throughput serum/plasma biomarker assays to evaluate utility of a biomarker panel consisting of CLIC1, CLIC4 and CA125. (PMID:30282979)
- through profilin-1 binding, CLIC4 functions in a RhoA-mDia2-regulated signaling network to integrate cortical actin assembly and membrane protrusion (PMID:30381396)
- CLIC4 regulates late endosomal trafficking and matrix degradation activity of MMP14 at focal adhesions in RPE cells. (PMID:31439888)
- Cellular CLIC1 and CLIC4 are required for efficient Chikungunya virus replication. (PMID:31483794)
- CLIC4 abrogation promotes epithelial-mesenchymal transition in gastric cancer. (PMID:31560739)
- CLIC4 and CLIC1 bridge plasma membrane and cortical actin network for a successful cytokinesis. (PMID:31879279)
- Chloride intracellular channel 4 is dysregulated in endometrium of women with infertility and alters receptivity. (PMID:32807494)
- The intracellular chloride channel 4 (CLIC4) activates systemic sclerosis fibroblasts. (PMID:33331912)
- Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro. (PMID:33439448)
- Detection of Cells Displaying High Expression of CLIC4 in Tumor Tissue of Patients With Colorectal Cancer. (PMID:34697147)
- Characterization of chloride intracellular channel 4 in the regulation of human trophoblast function. (PMID:35078024)
- Circular RNA_0033596 aggravates endothelial cell injury induced by oxidized low-density lipoprotein via microRNA-217-5p /chloride intracellular channel 4 axis. (PMID:35081862)
- Induction of Pro-Fibrotic CLIC4 in Dermal Fibroblasts by TGF-beta/Wnt3a Is Mediated by GLI2 Upregulation. (PMID:35159339)
Cross-species orthologs
34 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | clic4 | ENSDARG00000022995 |
| mus_musculus | Clic4 | ENSMUSG00000037242 |
| rattus_norvegicus | Clic4 | ENSRNOG00000018109 |
| drosophila_melanogaster | GstD1 | FBGN0001149 |
| drosophila_melanogaster | GstD2 | FBGN0010038 |
| drosophila_melanogaster | GstD3 | FBGN0010039 |
| drosophila_melanogaster | GstD4 | FBGN0010040 |
| drosophila_melanogaster | GstD5 | FBGN0010041 |
| drosophila_melanogaster | GstD6 | FBGN0010042 |
| drosophila_melanogaster | GstD7 | FBGN0010043 |
| drosophila_melanogaster | GstD8 | FBGN0010044 |
| drosophila_melanogaster | GstE12 | FBGN0027590 |
| drosophila_melanogaster | Clic | FBGN0030529 |
| drosophila_melanogaster | GstT3 | FBGN0031117 |
| drosophila_melanogaster | GstE13 | FBGN0033381 |
| drosophila_melanogaster | GstE1 | FBGN0034335 |
| drosophila_melanogaster | GstE11 | FBGN0034354 |
| drosophila_melanogaster | GstD9 | FBGN0038020 |
| drosophila_melanogaster | GstD10 | FBGN0042206 |
| drosophila_melanogaster | GstT1 | FBGN0050000 |
| drosophila_melanogaster | GstT2 | FBGN0050005 |
| drosophila_melanogaster | GstE9 | FBGN0063491 |
| drosophila_melanogaster | GstE8 | FBGN0063492 |
| drosophila_melanogaster | GstE7 | FBGN0063493 |
| drosophila_melanogaster | GstE6 | FBGN0063494 |
| drosophila_melanogaster | GstE5 | FBGN0063495 |
| drosophila_melanogaster | GstE4 | FBGN0063496 |
| drosophila_melanogaster | GstE3 | FBGN0063497 |
| drosophila_melanogaster | GstE2 | FBGN0063498 |
| drosophila_melanogaster | GstE10 | FBGN0063499 |
| caenorhabditis_elegans | exc-4 | WBGENE00001365 |
| caenorhabditis_elegans | WBGENE00001371 | |
| caenorhabditis_elegans | gst-43 | WBGENE00001791 |
| caenorhabditis_elegans | WBGENE00021817 |
Paralogs (14): GSTO2 (ENSG00000065621), GSTT2 (ENSG00000099984), GSTZ1 (ENSG00000100577), GDAP1 (ENSG00000104381), CLIC5 (ENSG00000112782), GDAP1L1 (ENSG00000124194), GSTT2B (ENSG00000133433), GSTO1 (ENSG00000148834), CLIC2 (ENSG00000155962), CLIC6 (ENSG00000159212), CLIC3 (ENSG00000169583), CLIC1 (ENSG00000213719), EEF1G (ENSG00000254772), GSTT4 (ENSG00000276950)
Protein
Protein identifiers
Chloride intracellular channel protein 4 — Q9Y696 (reviewed: Q9Y696)
Alternative names: Glutaredoxin-like oxidoreductase CLIC4, Intracellular chloride ion channel protein p64H1
All UniProt accessions (2): Q9Y696, Q6FIC5
UniProt curated annotations — full annotation on UniProt →
Function. In the soluble state, catalyzes glutaredoxin-like thiol disulfide exchange reactions with reduced glutathione as electron donor. Can insert into membranes and form voltage-dependent multi-ion conductive channels. Membrane insertion seems to be redox-regulated and may occur only under oxidizing conditions. Has alternate cellular functions like a potential role in angiogenesis or in maintaining apical-basolateral membrane polarity during mitosis and cytokinesis. Could also promote endothelial cell proliferation and regulate endothelial morphogenesis (tubulogenesis). Promotes cell-surface expression of HRH3.
Subunit / interactions. Component of a multimeric complex consisting of several cytoskeletal proteins, including actin, ezrin, alpha-actinin, gelsolin, IQGAP1 and CLIC5A. Binds directly to brain dynamin I in a complex containing actin, tubulin and 14-3-3 isoforms. Monomer. Interacts with HRH3. Interacts with AKAP9.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Cytoplasmic vesicle membrane. Nucleus. Cell membrane. Mitochondrion. Cell junction. Endoplasmic reticulum membrane.
Tissue specificity. Detected in epithelial cells from colon, esophagus and kidney (at protein level). Expression is prominent in heart, kidney, placenta and skeletal muscle.
Activity regulation. Inhibited by rapamycin, amphotericin B and IAA-94.
Domain organisation. The active G-site contains a monothiol Cys-X-X-Ser motif which mediates glutathione-dependent redox catalysis. Members of this family may change from a globular, soluble state to a state where the N-terminal domain is inserted into the membrane and functions as a chloride channel. The redox status of the active cysteine in Cys-X-X-Cys/Ser motif likely determines the capacity to adopt a soluble or membrane-inserted state. A conformation change of the N-terminal domain is thought to expose hydrophobic surfaces that trigger membrane insertion.
Induction. Up-regulated by calcium ions in differentiating keratinocytes. Up-regulated in myofibroblasts.
Similarity. Belongs to the chloride channel CLIC family.
RefSeq proteins (1): NP_039234* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002946 | CLIC | Family |
| IPR010987 | Glutathione-S-Trfase_C-like | Domain |
| IPR036249 | Thioredoxin-like_sf | Homologous_superfamily |
| IPR036282 | Glutathione-S-Trfase_C_sf | Homologous_superfamily |
| IPR040079 | Glutathione_S-Trfase | Family |
| IPR053823 | CLIC_N | Domain |
Pfam: PF22441
Catalyzed reactions (Rhea), 7 shown:
- chloride(in) = chloride(out) (RHEA:29823)
- choline(out) = choline(in) (RHEA:32751)
- nitrate(in) = nitrate(out) (RHEA:34923)
- iodide(out) = iodide(in) (RHEA:66324)
- thiocyanate(in) = thiocyanate(out) (RHEA:75347)
- bromide(in) = bromide(out) (RHEA:75383)
- fluoride(in) = fluoride(out) (RHEA:76159)
UniProt features (38 total): helix 11, modified residue 8, strand 6, sequence conflict 4, turn 3, initiator methionine 1, chain 1, transmembrane region 1, domain 1, region of interest 1, short sequence motif 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2AHE | X-RAY DIFFRACTION | 1.8 |
| 3OQS | X-RAY DIFFRACTION | 2 |
| 2D2Z | X-RAY DIFFRACTION | 2.2 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y696-F1 | 91.97 | 0.80 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (8): 132, 167, 236, 244, 2, 4, 24, 130
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 484 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_DN, GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_ENDOTHELIAL_CELL_DEVELOPMENT, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, KAAB_FAILED_HEART_ATRIUM_DN, GOBP_EPITHELIAL_CELL_DEVELOPMENT, GOBP_GROWTH, GOCC_CELL_SURFACE, GOBP_INORGANIC_ANION_TRANSPORT, TGACCTY_ERR1_Q2, AMIT_SERUM_RESPONSE_40_MCF10A, MODULE_503
GO Biological Process (17): angiogenesis (GO:0001525), endothelial cell morphogenesis (GO:0001886), chloride transport (GO:0006821), vacuolar acidification (GO:0007035), fertilization (GO:0009566), cell differentiation (GO:0030154), keratinocyte differentiation (GO:0030216), negative regulation of cell migration (GO:0030336), establishment or maintenance of apical/basal cell polarity (GO:0035088), multicellular organism growth (GO:0035264), branching morphogenesis of an epithelial tube (GO:0048754), regulation of cytoskeleton organization (GO:0051493), retina vasculature morphogenesis in camera-type eye (GO:0061299), cellular response to calcium ion (GO:0071277), monoatomic ion transport (GO:0006811), monoatomic ion transmembrane transport (GO:0034220), chloride transmembrane transport (GO:1902476)
GO Molecular Function (3): chloride channel activity (GO:0005254), oxidoreductase activity (GO:0016491), protein binding (GO:0005515)
GO Cellular Component (25): cytoplasm (GO:0005737), mitochondrion (GO:0005739), endoplasmic reticulum membrane (GO:0005789), centrosome (GO:0005813), cytosol (GO:0005829), plasma membrane (GO:0005886), microvillus (GO:0005902), cell-cell junction (GO:0005911), cell surface (GO:0009986), actin cytoskeleton (GO:0015629), membrane (GO:0016020), nuclear matrix (GO:0016363), midbody (GO:0030496), cytoplasmic vesicle membrane (GO:0030659), chloride channel complex (GO:0034707), apical part of cell (GO:0045177), perinuclear region of cytoplasm (GO:0048471), extracellular exosome (GO:0070062), nucleus (GO:0005634), endoplasmic reticulum (GO:0005783), cytoskeleton (GO:0005856), microtubule cytoskeleton (GO:0015630), cytoplasmic vesicle (GO:0031410), monoatomic ion channel complex (GO:0034702), anchoring junction (GO:0070161)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 8 |
| cytoplasm | 4 |
| intracellular membrane-bounded organelle | 3 |
| blood vessel morphogenesis | 1 |
| anatomical structure formation involved in morphogenesis | 1 |
| endothelial cell development | 1 |
| epithelial cell morphogenesis | 1 |
| monoatomic anion transport | 1 |
| inorganic anion transport | 1 |
| intracellular pH reduction | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| cellular developmental process | 1 |
| epidermal cell differentiation | 1 |
| skin development | 1 |
| cell migration | 1 |
| regulation of cell migration | 1 |
| negative regulation of cell motility | 1 |
| establishment or maintenance of bipolar cell polarity | 1 |
| multicellular organismal process | 1 |
| developmental growth | 1 |
| tube morphogenesis | 1 |
| epithelial tube morphogenesis | 1 |
| morphogenesis of a branching epithelium | 1 |
| cytoskeleton organization | 1 |
| regulation of organelle organization | 1 |
| anatomical structure morphogenesis | 1 |
| retina vasculature development in camera-type eye | 1 |
| response to calcium ion | 1 |
| cellular response to metal ion | 1 |
| transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| chloride transport | 1 |
| monoatomic anion transmembrane transport | 1 |
| monoatomic anion channel activity | 1 |
| chloride transmembrane transporter activity | 1 |
| catalytic activity | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
1296 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CLIC4 | HIVEP2 | P31629 | 896 |
| CLIC4 | HRH3 | Q9Y5N1 | 770 |
| CLIC4 | PPM1A | P35813 | 750 |
| CLIC4 | SMAD3 | P84022 | 706 |
| CLIC4 | CLCN4 | P51793 | 683 |
| CLIC4 | PHC3 | Q8NDX5 | 682 |
| CLIC4 | EZR | P15311 | 673 |
| CLIC4 | SLC16A8 | O95907 | 629 |
| CLIC4 | HIVEP1 | P15822 | 588 |
| CLIC4 | AQP1 | P29972 | 558 |
| CLIC4 | SMAD2 | Q15796 | 535 |
| CLIC4 | MYC | P01106 | 527 |
| CLIC4 | CAV1 | Q03135 | 464 |
| CLIC4 | DNM1 | Q05193 | 460 |
| CLIC4 | TGFB1 | P01137 | 445 |
IntAct
25 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TPRN | CLIC4 | psi-mi:“MI:0915”(physical association) | 0.670 |
| CLIC4 | CLIC2 | psi-mi:“MI:0914”(association) | 0.530 |
| Kpna2 | CLIC4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SDC1 | ILVBL | psi-mi:“MI:0915”(physical association) | 0.400 |
| HSP90AB1 | CLIC4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CLIC4 | REL | psi-mi:“MI:0915”(physical association) | 0.370 |
| Cdc16 | ANAPC15 | psi-mi:“MI:0914”(association) | 0.350 |
| Anapc16 | ANAPC15 | psi-mi:“MI:0914”(association) | 0.350 |
| MAPT | LANCL1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRNP | CARNS1 | psi-mi:“MI:0914”(association) | 0.350 |
| GATD3 | NME1 | psi-mi:“MI:0914”(association) | 0.350 |
| GATD3 | NDUFS2 | psi-mi:“MI:0914”(association) | 0.350 |
| EGFR | ENO1 | psi-mi:“MI:0914”(association) | 0.350 |
| SAR1B | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | psi-mi:“MI:0914”(association) | 0.350 | |
| CACYBP | PSMD11 | psi-mi:“MI:0914”(association) | 0.350 |
| CFTR | UBA6 | psi-mi:“MI:2364”(proximity) | 0.270 |
| HLA-B | psi-mi:“MI:2364”(proximity) | 0.270 | |
| MCC | CLIC4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CLIC4 | TPRN | psi-mi:“MI:0915”(physical association) | 0.000 |
| CLIC6 | CLIC4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (161): CLIC2 (Affinity Capture-MS), CLIC6 (Affinity Capture-MS), CLIC5 (Affinity Capture-MS), TPRN (Affinity Capture-MS), CLIC4 (Co-fractionation), CLIC4 (Co-fractionation), CLIC4 (Co-fractionation), CLIC4 (Co-fractionation), CLIC4 (Co-fractionation), CLIC4 (Co-fractionation), CLIC4 (Co-fractionation), CLIC4 (Co-fractionation), CLIC4 (Co-fractionation), CLIC4 (Co-fractionation), CLIC4 (Co-fractionation)
ESM2 similar proteins: A0A1U8QXK4, A8XWD1, O00299, O15247, O45405, O45503, O62471, O64471, O95833, P14693, P34599, Q03606, Q08BC6, Q0II26, Q13155, Q22949, Q29LT4, Q32PX2, Q4VBW0, Q5E9B7, Q5M883, Q5R957, Q6DF78, Q6MG61, Q6NRQ2, Q7YTB0, Q8BXK9, Q8R010, Q8T773, Q8WQA4, Q95MF9, Q99K01, Q9CAS6, Q9D7P7, Q9EPT8, Q9HE00, Q9QYB1, Q9TYN3, Q9UGL1, Q9V8W3
Diamond homologs: O00299, O15247, O95833, P35526, Q29238, Q5E9B7, Q5M883, Q5R957, Q6MG61, Q811Q2, Q8BHB9, Q8BXK9, Q95MF9, Q96NY7, Q9D7P7, Q9EPT8, Q9N2G5, Q9NZA1, Q9QYB1, Q9XSA7, Q9Y696, Q9Z0W7, Q9Z1Q5, O45405, Q9VY78, P81124, Q9FRL8, Q8WQA4
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CDK5 | “up-regulates quantity by stabilization” | CLIC4 | phosphorylation |
Disease & clinical
Clinical variants and AI predictions
ClinVar
28 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 19 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 599503 | NM_013943.3(CLIC4):c.220C>T (p.His74Tyr) | Likely pathogenic |
SpliceAI
1719 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:24745626:G:GA | donor_loss | 1.0000 |
| 1:24745626:G:GG | donor_gain | 1.0000 |
| 1:24797737:TCCA:T | acceptor_loss | 1.0000 |
| 1:24797738:CCA:C | acceptor_loss | 1.0000 |
| 1:24797739:CAG:C | acceptor_loss | 1.0000 |
| 1:24797740:AGG:A | acceptor_loss | 1.0000 |
| 1:24797740:AGGCT:A | acceptor_gain | 1.0000 |
| 1:24797741:GGCTG:G | acceptor_gain | 1.0000 |
| 1:24797847:AAAAG:A | donor_loss | 1.0000 |
| 1:24797848:AAAGG:A | donor_loss | 1.0000 |
| 1:24797849:AAGGT:A | donor_loss | 1.0000 |
| 1:24797852:G:C | donor_loss | 1.0000 |
| 1:24797853:T:G | donor_loss | 1.0000 |
| 1:24814088:CAACA:C | acceptor_loss | 1.0000 |
| 1:24814092:A:AG | acceptor_gain | 1.0000 |
| 1:24814092:AG:A | acceptor_gain | 1.0000 |
| 1:24814093:G:GG | acceptor_gain | 1.0000 |
| 1:24814093:GG:G | acceptor_gain | 1.0000 |
| 1:24814093:GGA:G | acceptor_gain | 1.0000 |
| 1:24814093:GGAA:G | acceptor_gain | 1.0000 |
| 1:24814215:CCCAA:C | donor_gain | 1.0000 |
| 1:24814216:CCAA:C | donor_gain | 1.0000 |
| 1:24814217:CAA:C | donor_gain | 1.0000 |
| 1:24814218:AA:A | donor_gain | 1.0000 |
| 1:24814220:G:GG | donor_gain | 1.0000 |
| 1:24814220:G:T | donor_loss | 1.0000 |
| 1:24814221:TGA:T | donor_loss | 1.0000 |
| 1:24814222:GAG:G | donor_loss | 1.0000 |
| 1:24814223:AG:A | donor_loss | 1.0000 |
| 1:24814232:GAAAA:G | donor_gain | 1.0000 |
AlphaMissense
1688 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:24745615:T:C | L21P | 1.000 |
| 1:24797766:G:A | G33R | 1.000 |
| 1:24797766:G:C | G33R | 1.000 |
| 1:24797767:G:A | G33E | 1.000 |
| 1:24797767:G:T | G33V | 1.000 |
| 1:24797772:T:C | C35R | 1.000 |
| 1:24797774:C:G | C35W | 1.000 |
| 1:24797778:T:C | F37L | 1.000 |
| 1:24797780:T:A | F37L | 1.000 |
| 1:24797780:T:G | F37L | 1.000 |
| 1:24797788:G:T | R40M | 1.000 |
| 1:24797793:T:C | F42L | 1.000 |
| 1:24797795:C:A | F42L | 1.000 |
| 1:24797795:C:G | F42L | 1.000 |
| 1:24797803:T:C | L45P | 1.000 |
| 1:24797823:T:C | F52L | 1.000 |
| 1:24797825:T:A | F52L | 1.000 |
| 1:24797825:T:G | F52L | 1.000 |
| 1:24797839:T:A | V57D | 1.000 |
| 1:24814108:T:C | L66P | 1.000 |
| 1:24814126:G:A | G72E | 1.000 |
| 1:24814135:C:A | P75Q | 1.000 |
| 1:24814137:C:T | P76S | 1.000 |
| 1:24814138:C:A | P76Q | 1.000 |
| 1:24814140:T:C | F77L | 1.000 |
| 1:24814142:T:A | F77L | 1.000 |
| 1:24814142:T:G | F77L | 1.000 |
| 1:24827054:G:A | G118E | 1.000 |
| 1:24827065:T:C | F122L | 1.000 |
| 1:24827067:T:A | F122L | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000013824 (1:24759317 T>C,G), RS1000014631 (1:24764577 C>A), RS1000016406 (1:24804557 ATG>A), RS1000195705 (1:24765573 G>C), RS1000220400 (1:24816014 C>T), RS1000236815 (1:24752566 A>G), RS1000255797 (1:24807065 A>C), RS1000264186 (1:24817071 C>A), RS1000317803 (1:24772711 C>T), RS1000417991 (1:24778899 A>G), RS1000429275 (1:24824297 C>G), RS1000430636 (1:24768030 G>A,C), RS1000452426 (1:24813338 G>A,T), RS1000453017 (1:24826370 G>A), RS1000494395 (1:24765973 G>A)
Disease associations
OMIM: gene MIM:606536 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000817_151 | Height | 2.000000e-12 |
| GCST005168_2 | Systolic blood pressure | 1.000000e-06 |
| GCST006661_182 | Male-pattern baldness | 1.000000e-10 |
| GCST006661_258 | Male-pattern baldness | 5.000000e-21 |
| GCST006979_867 | Heel bone mineral density | 1.000000e-13 |
| GCST90000025_907 | Appendicular lean mass | 2.000000e-12 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006335 | systolic blood pressure |
| EFO:0009270 | heel bone mineral density |
| EFO:0004980 | appendicular lean mass |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6067411 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 7.27 | Kd | 53.36 | nM | CHEMBL5653589 |
| 7.27 | ED50 | 53.36 | nM | CHEMBL5653589 |
| 6.62 | Kd | 237.4 | nM | CHEMBL3752910 |
| 6.62 | ED50 | 237.4 | nM | CHEMBL3752910 |
PubChem BioAssay actives
2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148081: Binding affinity to human CLIC4 incubated for 45 mins by Kinobead based pull down assay | kd | 0.0534 | uM |
| 4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148081: Binding affinity to human CLIC4 incubated for 45 mins by Kinobead based pull down assay | kd | 0.2374 | uM |
CTD chemical–gene interactions
87 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression | 6 |
| sodium arsenite | increases expression, affects expression, decreases expression | 4 |
| bisphenol A | affects cotreatment, decreases expression, increases expression | 3 |
| Smoke | decreases expression, increases abundance | 3 |
| cobaltous chloride | decreases expression, increases expression | 2 |
| entinostat | affects cotreatment, increases expression | 2 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression, increases expression | 2 |
| Arsenic Trioxide | increases expression | 2 |
| Benzo(a)pyrene | decreases expression, increases expression | 2 |
| Cisplatin | affects cotreatment, decreases expression, increases expression | 2 |
| Tobacco Smoke Pollution | affects expression, increases expression | 2 |
| Tretinoin | decreases expression, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| bisphenol F | affects cotreatment, decreases expression | 1 |
| testosterone enanthate | affects expression | 1 |
| methylmercuric chloride | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bis(tri-n-butyltin)oxide | increases expression | 1 |
| pyrogallol 1,3-dimethyl ether | decreases expression, affects cotreatment, affects localization | 1 |
| tributyltin | increases expression | 1 |
| trichostatin A | affects expression | 1 |
| 2,4,5,2’,4’,5’-hexachlorobiphenyl | increases expression, decreases reaction | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| butyraldehyde | increases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| ochratoxin A | increases expression | 1 |
| didecyldimethylammonium | increases expression | 1 |
| nickel sulfate | increases expression | 1 |
| methylmercury II | increases expression | 1 |
| beta-methylcholine | affects expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5651123 | Binding | Binding affinity to human CLIC4 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): alopecia